[Adenocarcinoma of the cervix--analysis of 363 cases].
Form 1959 through to May, 1993, 363 patients with adenocarcinoma of uterine cervix were initially treated which accounted for 2.5% of all initially treated cases of cervical carcinoma. Patients' mean age was 50.5 years. Forty-six percent of the patients were post-menopausal. The main symptom was irregular vaginal and/or discharge. Over 88% of the cases were in stage II and III of the disease. They were treated with radiotherapy alone. The overall 5-year survival rate was 51.8%. The recurrence rate was 17.4% with a mean time to recurrence of 33.3 months. Thirteen patients recurred beyond 5 years. Recurrence was accompanied with lung metastasis in 17 patients and supraclavicular eymph node metastases in 11. Among patients whose tumor recurred the 1- and 2-year survival rate were 35.2% and 19.2% respectively. The most significant prognostic factors were the stage of disease, the size of the tumor and the histologic subtypes
Ma
S
S
Cancer Hospital, Chinese Academy of Medical Sciences, Beijing.
Lin
D
D
Sun
J
J
D000230:Adenocarcinoma / Q000401:mortality / Q000473:pathology / Q000532:radiotherapy*; D002288:Adenocarcinoma, Mucinous / Q000401:mortality / Q000532:radiotherapy; D000328:Adult; D000368:Aged; D005260:Female; D006801:Humans; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local; D012189:Retrospective Studies; D015996:Survival Rate; D002583:Uterine Cervical Neoplasms / Q000401:mortality / Q000473:pathology / Q000532:radiotherapy*